You have no items in your shopping cart.
Description
Images & Validation
−| Tested Applications | ELISA, FA, FACS, Kinetics |
|---|---|
| Reactivity | Human |
Key Properties
−| Clonality | Monoclonal |
|---|---|
| Isotype | IgG |
| Target | SIRPa / CD172a |
| Molecular Weight | 145.5 kDa |
| Purity | > 95% |
| Endotoxin | < 1 EU/mg |
| Conjugation | Unconjugated |
Storage & Handling
−| Storage | Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. |
|---|---|
| Buffer/Preservatives | 100 mM Pro-Ac 20 mM Arg pH 5.0 |
| Expiration Date | 12 months from date of receipt. |
| Disclaimer | For research use only |
Similar Products
−Anti-SIRPa / CD172a Reference Antibody (Hospital for Sick Children patent anti-SIRPA) [orb1818228]
ELISA, FC
Human
Monoclonal
Unconjugated
100 μgAnti-SIRPa / CD172a Reference Antibody (BI 765063) [orb1805487]
ELISA, FA, FACS, Kinetics
Human
Monoclonal
Unconjugated
50 μg, 100 μg, 1 mgAnti-SIRPa / CD172a Reference Antibody (BI 765063) [orb1817811]
ELISA, FC
Human
Monoclonal
Unconjugated
100 μg

Quality Guarantee
Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Anti-SIRPa / CD172a Reference Antibody (Hospital for Sick Children patent anti-SIRPA) on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95%.

The purity of Anti-SIRPa / CD172a Reference Antibody (Hospital for Sick Children patent anti-SIRPA)is more than 95% ;determined by SEC-HPLC.

Immobilized human SIRPα V1 FC at4 μg/mL can bind Anti-SIRPa / CD172a Reference Antibody (Hospital for Sick Children patent anti-SIRPA);EC50=0.007292μg/mL.

Hospital for Sick Children patent anti-SIRPA FACS Blocking was evaluated using human CCRF-CEM cells. The IC50 was approximately 3.289 ug/ml.nM.
Quick Database Links
Documents Download
Request a Document
Protocol Information
Anti-SIRPa / CD172a Reference Antibody (orb1806109)
Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.
Login to Submit a Review






